HIGHLIGHTS
- who: Maria Letizia Calandrella from the Azienda Ospedaliera Santa Maria, Terni, Italy have published the paper: Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches. An ImGO pilot study, in the Journal: (JOURNAL)
- what: The aim of the study was to evaluate (MMR) and Nectin-4 immunohistochemical expression in UTUC looking also for an eventual correlation between these molecular features. This study showed a superior survival benefit of pembrolizumab versus the standard of care in all subgroup. The present analysis has several . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.